Anti-YME1L1 antibody produced in rabbit，100UL，HPA066953-100UL，Sigma

General description

ATP-dependent zinc metalloprotease YME1L1 is an enzyme encoded by YME1L1 gene. It belongs to the family of ATPases associated with a variety of cell activities (AAA family). In the human chromosome, it is localized on 10p12.1. YME1L is homologous to yeast YME1. The protein encoded by this gene has 716 amino acids.

Immunogen

YME1-like 1 ATPase

Application

All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the industry.

The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. We also provide Prestige Antibodies^® protocols and other useful information.
Anti-YME1L1 recognises YME1L1 protein.

Biochem/physiol Actions

ATP-dependent zinc metalloprotease YME1L1 protects the mitochondria, regulates the movement of proteins across the mitochondrial membrane and the proteolysis of misfolded proteins. It also controls the mitochondrial dynamics. YME1L1 controls the formation of respiratory chain molecules by proteolysis and maintains the cristae structure. YME1L1 helps mitochondria to adjust to different types of stress. In humans, mutations in YME1L1 leads to mitochondriopathy with optic nerve atrophy and mitochondrial network fragmentation. YME1L1 is associated with hereditary spastic paraplegia and other neurodegenerative disorders.

Features and Benefits

Prestige Antibodies^® are highly characterized and extensively validated antibodies with the added benefit of all available characterization data for each target being accessible via the Human Protein Atlas portal linked just below the product name at the top of this page. The uniqueness and low cross-reactivity of the Prestige Antibodies^® to other proteins are due to a thorough selection of antigen regions, affinity purification, and stringent selection. Prestige antigen controls are available for every corresponding Prestige Antibody and can be found in the linkage section.

Every Prestige Antibody is tested in the following ways:

• IHC tissue array of 44 normal human tissues and 20 of the most common cancer type tissues.
• Protein array of 364 human recombinant protein fragments.

Physical form

Solution in phosphate-buffered saline, pH 7.2, containing 40% glycerol and 0.02% sodium azide.

Other Notes

Corresponding Antigen APREST88359

Legal Information

Prestige Antibodies is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.